StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Rezolute total assets

Total assets on the balance sheet at the end of each period.

Rezolute's total assets was $96.01M at Sep 30, 2026. For fiscal 2026 it was $112.85M, down 35.7% from the year before. Over ten years it grew 26.3% a year on average. The highest annual figure on record is $175.49M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$112.85M-35.7%
FY2025Jun 30, 2025$175.49M+32.2%
FY2024Jun 30, 2024$132.74M+7.3%
FY2023Jun 30, 2023$123.72M-18.8%
FY2022Jun 30, 2022$152.42M+257.7%
FY2021Jun 30, 2021$42.61M+288.6%
FY2020Jun 30, 2020$10.97M-10.5%
FY2019Jun 30, 2019$12.25M+389.5%
FY2018Jun 30, 2018$2.50M-76.5%
FY2017Jun 30, 2017$10.63M-2.5%
FY2016Jun 30, 2016$10.90M-3.2%
FY2015Jun 30, 2015$11.26M+52.1%
FY2014Jun 30, 2014$7.40M+1208.7%
FY2011Dec 31, 2011$565.79K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$96.01M-39.5%
Q4 FY2026CQ2 2026Jun 30, 2026$112.85M-35.7%
Q3 FY2026CQ1 2026Mar 31, 2026$125.46M+32.4%
Q2 FY2026CQ4 2025Dec 31, 2025$138.63M+23.8%
Q1 FY2026CQ3 2025Sep 30, 2025$158.66M+28.6%
Q4 FY2025CQ2 2025Jun 30, 2025$175.49M+32.2%
Q3 FY2025CQ1 2025Mar 31, 2025$94.74M+8.0%
Q2 FY2025CQ4 2024Dec 31, 2024$112.01M+9.6%
Q1 FY2025CQ3 2024Sep 30, 2024$123.41M+9.2%
Q4 FY2024CQ2 2024Jun 30, 2024$132.74M+7.3%
Q3 FY2024CQ1 2024Mar 31, 2024$87.74M-34.6%
Q2 FY2024CQ4 2023Dec 31, 2023$102.15M-32.0%
Q1 FY2024CQ3 2023Sep 30, 2023$113.00M-27.6%
Q4 FY2023CQ2 2023Jun 30, 2023$123.72M-18.8%
Q3 FY2023CQ1 2023Mar 31, 2023$134.21M+92.9%
Q2 FY2023CQ4 2022Dec 31, 2022$150.21M+80.1%
Q1 FY2023CQ3 2022Sep 30, 2022$155.99M+302.4%
Q4 FY2022CQ2 2022Jun 30, 2022$152.42M+257.7%
Q3 FY2022CQ1 2022Mar 31, 2022$69.57M+111.3%
Q2 FY2022CQ4 2021Dec 31, 2021$83.41M+114.4%
Q1 FY2022CQ3 2021Sep 30, 2021$38.76M+423.1%
Q4 FY2021CQ2 2021Jun 30, 2021$42.61M+288.6%
Q3 FY2021CQ1 2021Mar 31, 2021$32.93M+124.0%
Q2 FY2021CQ4 2020Dec 31, 2020$38.90M+89.2%
Q1 FY2021CQ3 2020Sep 30, 2020$7.41M-72.1%
Q4 FY2020CQ2 2020Jun 30, 2020$10.97M-10.5%
Q3 FY2020CQ1 2020Mar 31, 2020$14.70M+487.3%
Q2 FY2020CQ4 2019Dec 31, 2019$20.57M+300.0%
Q1 FY2020CQ3 2019Sep 30, 2019$26.57M+320.3%
Q4 FY2019CQ2 2019Jun 30, 2019$12.25M+25.1%
Q4 FY2018CQ2 2018Jun 30, 2018$2.50M-76.5%
Q3 FY2018CQ1 2018Mar 31, 2018$5.14M-52.4%
Q2 FY2018CQ4 2017Dec 31, 2017$6.32M-36.4%
Q1 FY2018CQ3 2017Sep 30, 2017$9.80M-2.6%
Q4 FY2017CQ2 2017Jun 30, 2017$10.63M-2.5%
Q3 FY2017CQ1 2017Mar 31, 2017$10.80M+22.8%
Q2 FY2017CQ4 2016Dec 31, 2016$9.94M–
Q1 FY2017CQ3 2016Sep 30, 2016$10.06M–
Q4 FY2016CQ2 2016Jun 30, 2016$10.90M–
Q3 FY2016CQ1 2016Mar 31, 2016$8.79M–

More Rezolute figures

See a number that looks wrong?